Travoprost-Mepha Plus, gtt opht 0.04mg/5mg , 3 fl 2.5 ml

7680667300021 CH-66730 S01ED51
Travoprost-Mepha Plus, gtt opht 0.04mg/5mg , 3 fl 2.5 ml
Travoprost-Mepha Plus, gtt opht 0.04mg/5mg , 3 fl 2.5 ml
Travoprost-Mepha Plus, gtt opht 0.04mg/5mg , 3 fl 2.5 ml
1 / 3
google

Details

Product number
6673001
CPT
-
Packaging group
-
Unit
-

Articles (1)

Travoprost-Mepha Plus 0.04mg/5mg, Augentropfen
Augentropfen
3 x 2,5
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/02/2023
Patient information leaflet
Français
13/02/2023
Patient information leaflet
Italien
13/02/2023
Professional SmPC
Allemand
13/02/2023
Professional SmPC
Français
13/02/2023
Professional SmPC
Italien
13/02/2023

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 UG Substance Wirkstoff (Principe actif)
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
0.15 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 58.15
Specialties list
Yes
Generic
Yes
SL addition date: 01/01/2020

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
66730
Drug name
Travoprost-Mepha Plus, Augentropfen
Galenic form
AUL
ATC Code
S01ED51
Authorization status
Z
Dispensation category
B
First authorization
31/01/2019
Authorization expiration date
31/12/9999
IT number
11.09.0.
Domain
Human medicine
Field of application
Glaukom

Packaging details

Description (FR)
TRAVOPROST Mepha Plus 0.04mg/5mg 3 fl 2.5 ml
Description (DE)
TRAVOPROST Mepha Plus 0.04mg/5mg 3 Fl 2.5 ml
Narcotic (BTM)
No

Original drug

Azarga, Augentropfensuspension
CHF 30.70
View original

Other packaging sizes

TRAVOPROST Mepha Plus 0.04mg/5mg fl 2.5 ml
2,5 ML
View